BIOE — Bio Essence Income Statement
0.000.00%
Last trade - 00:00- $8.74m
- $9.98m
- $0.32m
Annual income statement for Bio Essence, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.959 | 0.888 | 0.622 | 0 | 0.324 |
| Cost of Revenue | |||||
| Gross Profit | 0.227 | 0.298 | 0.328 | 0 | 0.217 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.79 | 1.75 | 1.13 | 0.346 | 1.83 |
| Operating Profit | -0.833 | -0.858 | -0.511 | -0.346 | -1.51 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.593 | -0.644 | -0.525 | -0.403 | -1.56 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.596 | -0.648 | -0.528 | -0.405 | -1.57 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.596 | -0.648 | -0.81 | -0.972 | -1.31 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.596 | -0.648 | -0.81 | -0.972 | -1.31 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.018 | -0.02 | -0.016 | -0.012 | -0.023 |